1. Home
  2. SANA vs MMI Comparison

SANA vs MMI Comparison

Compare SANA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • MMI
  • Stock Information
  • Founded
  • SANA 2018
  • MMI 1971
  • Country
  • SANA United States
  • MMI United States
  • Employees
  • SANA N/A
  • MMI N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • MMI Real Estate
  • Sector
  • SANA Health Care
  • MMI Finance
  • Exchange
  • SANA Nasdaq
  • MMI Nasdaq
  • Market Cap
  • SANA 983.4M
  • MMI 1.2B
  • IPO Year
  • SANA 2021
  • MMI 2013
  • Fundamental
  • Price
  • SANA $3.32
  • MMI $32.33
  • Analyst Decision
  • SANA Strong Buy
  • MMI Hold
  • Analyst Count
  • SANA 5
  • MMI 1
  • Target Price
  • SANA $8.75
  • MMI N/A
  • AVG Volume (30 Days)
  • SANA 3.8M
  • MMI 104.3K
  • Earning Date
  • SANA 11-07-2025
  • MMI 11-07-2025
  • Dividend Yield
  • SANA N/A
  • MMI 1.57%
  • EPS Growth
  • SANA N/A
  • MMI N/A
  • EPS
  • SANA N/A
  • MMI N/A
  • Revenue
  • SANA N/A
  • MMI $725,903,000.00
  • Revenue This Year
  • SANA N/A
  • MMI $9.50
  • Revenue Next Year
  • SANA N/A
  • MMI $17.73
  • P/E Ratio
  • SANA N/A
  • MMI N/A
  • Revenue Growth
  • SANA N/A
  • MMI 17.89
  • 52 Week Low
  • SANA $1.26
  • MMI $27.61
  • 52 Week High
  • SANA $7.30
  • MMI $42.80
  • Technical
  • Relative Strength Index (RSI)
  • SANA 52.02
  • MMI 52.74
  • Support Level
  • SANA $3.00
  • MMI $31.79
  • Resistance Level
  • SANA $3.42
  • MMI $33.09
  • Average True Range (ATR)
  • SANA 0.21
  • MMI 0.76
  • MACD
  • SANA 0.04
  • MMI -0.10
  • Stochastic Oscillator
  • SANA 88.17
  • MMI 41.14

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Share on Social Networks: